Heather Sheardown, Queen's University

Research

Latest funding

Intravitreal delivery of Proteoglycan 4 for the treatment of dry age-related macular degeneration via a photoactivatable hydrogel platform.
CIHR · 2024 · Principal investigator
$569,924

Intravitreal delivery of Proteoglycan 4 for the treatment of dry age-related macular degeneration via a photoactivatable hydrogel platform.

Principal investigatorCIHR2024Project Grant

Principal investigators: Amsden, Brian G; Sheardown, Heather D

Keywords: Age-Related Macular Degeneration; Controlled Release; Hydrogel; Intravitreal Dug Administration; Ocular Drug Delivery; Photo-Activated Polymer Degradation; Protein Therapy; Proteoglycan 4

$569,924

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Mention their CIHR grant from 2024

Subject: Prospective PhD student: Age-Related Macular Degeneration Dear Professor Sheardown, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. Your research on age-related macular degeneration connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Intravitreal delivery of Proteoglycan 4 for the treatment of dry age-related macular degeneration via a photoactivatable hydrogel platform." (2024), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]